STATESVILLE, N.C., June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended...
After eight months of the 2024/25 financial year, the continuing operations have achieved a revenue growth of 7% to DKK 347 million (DKK 324 million), and the primary result (EBIT) amounts to DKK 28.5 million after 8 months (DKK 10.5 million in 2023/24).